Impact of myocardial viability assessed by myocardial perfusion imaging on ventricular tachyarrhythmias in cardiac resynchronization therapy

[1] Cleland JG(2006)Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase] Eur Heart J 27 1928-1932

[2] Daubert JC(2004)Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure (COMPANION) Investigators N Engl J Med 350 2140-2150

[3] Erdmann E(2009)Cardiac-resynchronization therapy for the prevention of heart-failure events N Engl J Med 361 1329-1338

[4] Freemantle N(2008)Antiarrhythmic effect of reverse ventricular remodeling induced by cardiac resynchronization therapy J Am Coll Cardiol 52 1442-1449

[5] Gras D(2011)Implantable cardioverter-defibrillator patients who are upgraded and respond to cardiac resynchronization therapy have less ventricular arrhythmias compared with nonresponders J Am Coll Cardiol 58 2282-2289

[6] Kappenberger L(2006)Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial Circulation 114 2766-2772

[7] Bristow MR(2003)Effect of epicardial or biventricular pacing to prolong QT interval and increase transmural dispersion of repolarization. Does resynchronization therapy pose a risk for patients predisposed to long QT or torsade de pointes? Circulation 107 740-746

[8] Saxon LA(2003)Increase in ventricular tachycardia frequency after biventricular implantable cardioverter defibrillator upgrade J Cardiovasc Electrophysiol 14 1245-1247

[9] Boehmer J(2007)Impact of viability and scar tissue on response to cardiac resynchronization therapy in ischaemic heart failure patients Eur Heart J 28 33-41

[10] Krueger S(2011)Impact of scar burden by single-photon emission computed tomography myocardial perfusion imaging on patient outcomes following cardiac resynchronization therapy Eur Heart J 32 93-103

[1] Cleland JG(2006)Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase] Eur Heart J 27 1928-1932

[2] Daubert JC(2004)Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure (COMPANION) Investigators N Engl J Med 350 2140-2150

[3] Erdmann E(2009)Cardiac-resynchronization therapy for the prevention of heart-failure events N Engl J Med 361 1329-1338

[4] Freemantle N(2008)Antiarrhythmic effect of reverse ventricular remodeling induced by cardiac resynchronization therapy J Am Coll Cardiol 52 1442-1449

[5] Gras D(2011)Implantable cardioverter-defibrillator patients who are upgraded and respond to cardiac resynchronization therapy have less ventricular arrhythmias compared with nonresponders J Am Coll Cardiol 58 2282-2289

[6] Kappenberger L(2006)Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial Circulation 114 2766-2772

[7] Bristow MR(2003)Effect of epicardial or biventricular pacing to prolong QT interval and increase transmural dispersion of repolarization. Does resynchronization therapy pose a risk for patients predisposed to long QT or torsade de pointes? Circulation 107 740-746

[8] Saxon LA(2003)Increase in ventricular tachycardia frequency after biventricular implantable cardioverter defibrillator upgrade J Cardiovasc Electrophysiol 14 1245-1247

[9] Boehmer J(2007)Impact of viability and scar tissue on response to cardiac resynchronization therapy in ischaemic heart failure patients Eur Heart J 28 33-41

[10] Krueger S(2011)Impact of scar burden by single-photon emission computed tomography myocardial perfusion imaging on patient outcomes following cardiac resynchronization therapy Eur Heart J 32 93-103